SCHEMBL4308487

SCHEMBL4308487

CCOC(=O)CC(=O)C(Cl)(Cl)Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.61
MGAM O43451 1/20 0.61
SI P14410 1/20 0.61
MGAM2 Q2M2H8 1/20 0.61
ALDH1A1 P00352 4/20 0.44
TRPA1 O75762 1/20 0.44
CYP1A2 P05177 1/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PKM P14618 1/20 0.38
ALOX15 P16050 2/20 0.37
SOAT1 P35610 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.36
HPGD P15428 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232689 0.84 GAA (0.58) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL19567 0.83 GAA (0.56) GAAMGAMSIMGAM2ALDH1A1
Malonic Acid Diethyl Ester SCHEMBL3670061 0.80 GAA (0.94) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL66328 0.79 GAA (0.64) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL8920059 0.78 GAA (0.48) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL24019183 0.78 GAA (0.50) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL27825811 0.77 GAA (0.61) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL77331 0.77 GAA (0.61) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL27728514 0.77 GAA (0.61) GAAMGAMSIMGAM2ALDH1A1
Malonic Acid Diethyl Ester SCHEMBL1331824 0.77 GAA (1.00) GAAMGAMSIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7056540-B2 Enzymatic process for the preparation of optically active alcohols from ketones using tuberous root Daucus carota COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-06-06 US claimed
US-20040082043-A1 Enzymatic process for the preparation of optically active alcohols from ketones using tuberous root daucus carota COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-04-29 US claimed
CN-122103032-A Preparation method and pesticide application of 1-methyl-3-trifluoromethyl-5-hydroxypyrazole 2026-05-29 CN disclosed
CN-118373740-A Aliphatic synthetic tanning agent containing octa-carbonyl and preparation method thereof 南京工业大学 2024-07-23 CN disclosed
CN-118344262-A Aliphatic synthetic tanning agent containing multifunctional structure and preparation method thereof 南京工业大学 2024-07-16 CN disclosed
CN-118125918-A Continuous synthesis method and synthesis device of 4, 4-trifluoro acetoacetic acid ethyl ester 淄博飞源化工有限公司 2024-06-04 CN disclosed
CN-114456290-A Catalyst system for olefin polymerization and prepolymerized catalyst composition 中国石油化工股份有限公司 2022-05-10 CN disclosed
CN-114456286-A Catalyst system for olefin polymerization and use thereof 中国石油化工股份有限公司 2022-05-10 CN disclosed
US-10568867-B2 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis GALAPAGOS NV (BE) 2020-02-25 US disclosed
US-10568867-B2 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis GALAPAGOS NV (BE) 2020-02-25 US disclosed
EP-3486246-A1 THIENO[2,3-C]PYRANS AS CFTR MODULATORS Galapagos N.V. (BE) 2019-05-22 EP disclosed
US-5696130-A Tricyclic steroid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-12-09 US disclosed
US-5693647-A Steroid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-12-02 US disclosed
US-5693646-A Steroid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-12-02 US disclosed
US-5688808-A Steroid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-11-18 US disclosed
US-5688810-A Steroid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-11-18 US disclosed
EP-0800519-A1 STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 EP disclosed
WO-1996019458-A2 STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 1996-06-27 WO disclosed
US-4607041-A CARDIOTONIC AGENTS FISONS PLC (GB) 1986-08-19 US disclosed
EP-0125803-A2 Pharmaceutically active dihydropyridines FISONS plc (GB) 1984-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10568867-B2 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis CFTR, ABCB11, PKD1 GAA 406/4885MGAM 2252/4885SI 988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.